netFormulary NHS
NHS Bath and North East Somerset, Swindon and Wiltshire ICB
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
 Search
 Formulary Chapter 5: Infections - Full Chapter
Notes:

Infections related Prescribing Guidance 

Please see our Prescribing Guidelines page for all prescribing guidance relating to this chapter.

The Primary care antibiotic guidance can be found here

Management of Infection Quick Ref Guide for Adults can be found here

Management of Infection Quick Ref Guide for Children can be found here

NHS National infection prevention and control manual for England

Using solid oral dosage form antibiotics in children – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice

Infections related Shared Care Agreements

Please see our Shared Care Agreements page for all shared care agreements (SCAs) relating to this chapter

Out-patient Antibiotic Therapy (OPAT) services across BSW:

GWH OPAT service:

OPAT Specialist Nurse - 01793 605032

Or alternatively contact switchboard on 01793 604020 and bleep 1108

OPAT Team working hours:

Monday to Friday 08:30am – 16:30pm

Other useful contact telephone numbers:

The PICC Team – 01793 605885 or bleep 2615

SEQOL – Swindon Community Nurses – 01793 646466

RUH OPAT service:

Direct line (with answerphone): 01225 821490

OR RUH switchboard and bleep 7467

Service is open Monday to Friday 8am to 4-4:30pm

Self-care

Many of the products in this chapter are available for purchase over-the-counter, and patients are encouraged to self-care, with the support of their community pharmacist, in the first instance.

For further information on self-care & the NHS, please refer to:

Conditions for which over the counter items should not routinely be prescribed in primary care: Guidance for CCGs
Chapter Links...
Link   NHS Easy read information: Sepsis
Link   NHSE Easy read info: Sepsis (e.g. how to avoid/spotting the signs/problems after sepsis)
Link   NICE Lyme disease: laboratory investigations and diagnosis. Visual summary
Link   PHE leaflet: Enjoy the outdoors but ’be tick aware’
Link   TARGET Information: Treating Your Infection (TYI) - Patient Info Leaflets
 Details...
05.04.01  Expand sub section  Antimalarials
 note 

Drugs for malarial prophylaxis cannot be prescribed on FP10 on the NHS.

The department of health advises GPs that private prescription forms should be used to prescribe drugs for malaria prophylaxis. Chloroquine and proguanil are available "Over The Counter" (OTC) whereas mefloquine and Malarone® require a private prescription.

Cost of treatment can vary between community pharmacies. Advise patients to obtain information of cost of dispensing private prescriptions for malaria prophylaxis from their community pharmacy.

For advice on malaria prophyaxis the following resources are available:

Please also note that doxycycline can be used for the treatment of falciparum malaria and is listed in section 5.1.3 (tetracyclines).
05.04.01  Expand sub section  Treatment of malaria
05.04.01  Expand sub section  Chloroquine
05.04.01  Expand sub section  Mefloquine
05.04.01  Expand sub section  Primaquine to top
05.04.01  Expand sub section  Proguanil
05.04.01  Expand sub section  Pyrimethamine
Pyrimethamine with Sulfadoxine (Fansidar®)
(Malaria treatment)
View adult BNF View SPC online 		Formulary
traffic lightRed
  • Treatment for Malaria is available on the NHS.
  • Patients requiring Malaria prevention must acquire this on a private prescription
  • Available from 'Special order' manufacturers or specialist-importing companies.
  • Pyrimethamine 25mg/ sulfadoxine 500mg tablets
 
 
05.04.01  Expand sub section  Quinine
05.04.01  Expand sub section  Tetracyclines
 ....
 Non Formulary Items
Pyrimethamine and Dapsone

View adult BNF View SPC online 		Non Formulary
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
 Display tracking information
click to search medicines.org.uk
 Link to adult BNF
click to search medicines.org.uk
 Link to SPCs
SMC
 Scottish Medicines Consortium
Cytotoxic Drug
 Cytotoxic Drug
CD
 Controlled Drug
High Cost Medicine
 High Cost Medicine
Cancer Drugs Fund
 Cancer Drugs Fund
NHSE
 NHS England
Homecare
 Homecare
CCG
 CCG
Green Low Carbon

Low carbon footprint
Amber Medium Carbon

Medium carbon footprint
Red High carbon footprint

High carbon footprint

Traffic Light Status Information

Status Description

Red

 RED - These medicines are considered suitable for prescribing ONLY by a specialist clinician throughout treatment. The specialist clinician is commonly situated in a hospital but may be within a virtual ward or a locally commissioned specialist-led service situated in primary care or other community setting. General non-specialist prescribing of a RED TLS medicine is NOT recommended unless there is a specific protocol under direct authority of a specialist employed within BSW set up to support this.   

Amber

 AMBER - These medicines are considered suitable for prescribing in primary care following specialist initiation or recommendation.   

Amber with Shared Care

 AMBER with Shared Care - These medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and primary care by a Shared Care Agreement (SCA). If no SCA in place status reverts to red.   

Green

 GREEN - These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations.   

Self

 SELF-CARE medicines are suitable for patients to be directed to buy themselves   

Black

 BLACK - Black TLS (in use from Oct 2020) Used where a decision has been made by the BSW APC not to routinely commission this preparation for its licensed indications. Do not prescribe.   

Grey

 Not currently used. We intend to include this TLS in future to highlight where a decision to use this medicine is under review.  

Red Specialist Centre

 Not currently used. We intend to include this TLS in future to highlight where this medicine and indication is ONLY available through a Specialist Centre according to a NICE Highly Specialised Technology or NHSE Specialised Commission Circular / Policy.  

netFormulary